Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning

BACKGROUND: Phenytoin is widely used as primary seizure prophylaxis in hematopoietic stem cell transplantation in patients undergoing myeloablative conditioning with busulfan. Because of the negative side effects of phenytoin, we abandoned phenytoin use in these patients. To assess the effect of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Germeraad, R. S., Demandt, A. M. P., Rouhl, R. P. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441567/
https://www.ncbi.nlm.nih.gov/pubmed/36071908
http://dx.doi.org/10.3389/fneur.2022.928550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441567/
https://www.ncbi.nlm.nih.gov/pubmed/36071908
http://dx.doi.org/10.3389/fneur.2022.928550

Ejemplares similares